Chase Therapeutics Announces $20 Million Series B Financing To Advance Clinical Trials In Parkinson’S Disease And Major Depressive Disorder
Amount Raised
$20 Million
Round Type
Series B
WashingtonBiotechnologyHealth CareMedicalTherapeuticsDescription
Chase Therapeutics Corporation, a Washington, DC based clinical stage pharmaceutical company, today announced the completion of a milestone-based $20M Series B financing led by Chinalink Asia Holdings of Hong Kong. This new round builds on the earlier financings from Brain Trust Accelerator Fund II of Burlingame, CA, and the Rise of the Rest Fund and Makana Holdings of Washington, DC. The company also announced that Javier Romero, Chairman and CEO of Chinalink, will join the Board of Directors.
Quick answer
Chase Therapeutics Corporation raised $20 Million in a Series B round, dated October 20, 2021. Chase Therapeutics Corporation is based in Washington, United States.
- How much did Chase Therapeutics Corporation raise?
- Chase Therapeutics Corporation raised $20 Million in a Series B round on October 20, 2021.
- What does Chase Therapeutics Corporation do?
- Chase Therapeutics Corporation specializes in developing innovative treatments for neuropsychiatric disorders.
- Where is Chase Therapeutics Corporation based and how big is it?
- Chase Therapeutics Corporation is based in Washington, United States.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Chase Therapeutics Corporation that raised within 45 days of this round, from Fundz verified event records.
- Acrivon Therapeutics raised $100M on November 23, 2021.
- Compugen raised $20M on November 22, 2021.
- Acrivon Therapeutics raised $100M (Series B) on November 11, 2021.
- MAIA Biotechnology raised $6.2M (Funding Round) on October 14, 2021.
- CytoDyn raised $11M on December 3, 2021.
- medimaps group S.A raised $20M (Funding Round) on December 1, 2021.
Who to call at Chase Therapeutics Corporation, and when
A new round usually means Chase Therapeutics Corporation is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Chase Therapeutics Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Chase Therapeutics Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Chase Therapeutics Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Chase Therapeutics Corporation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansChase Therapeutics Corporation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.